Images are for illustrative purposes only. Not real patient or data.

§ The LibreLinkUp app is only compatible with certain mobile device and operating systems. Please check www.librelinkup.com for more information about device compatibility before using the app. Use of LibreLinkUp requires registration with LibreView. The LibreLinkUp mobile app is not intended to be a primary glucose monitor: home users must consult their primary device(s) and consult a healthcare professional before making any medical interpretation and therapy adjustments from the information provided by the app.

* FreeStyle Libre apps refers to the FreeStyle LibreLink and FreeStyle Libre 3 apps

^ Sharing of glucose data requires registration with LibreView. Automatic upload to LibreView requires a wireless internet connection or mobile data connection.

◊ The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Please check the website for more information about device compatibility before using the app. Use of FreeStyle LibreLink may require registration with LibreView.

◊◊ The FreeStyle Libre 3 app is only compatible with certain mobile devices and operating systems. Please check our website for more information about device compatibility before using the app. Sharing of glucose data requires registration with LibreView.

ǁ The user’s device must have internet connectivity for glucose data to automatically upload to LibreView and to transfer to connected LibreLinkUp app users.

Ѱ For children aged 4-12 using FreeStyle Libre 2 sensor or children aged 2-12 using FreeStyle Libre 2 Plus sensor, a caregiver at least 18 years old is responsible for supervising, managing, and assisting them in using the FreeStyle Libre system and interpreting its readings.

† Finger pricks are required if glucose readings and alarms do not match symptoms or expectations.

₼ The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose device data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.

1. Hilliard, M., et al. Diabetes Technology & Therapeutics. (2019): https:/doi.org/10.1089/dia.2019.0142.

2. Data on file, Abbott Diabetes Care, Inc.